Alseres Pharmaceuticals Inc (ALSE)
0.01
0.00 (0.00%)
USD |
OTCM |
Jun 27, 16:00
Alseres Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2014 | -0.7395 |
March 31, 2014 | -0.7378 |
December 31, 2013 | -0.7336 |
September 30, 2013 | -0.2418 |
June 30, 2013 | -0.2369 |
March 31, 2013 | -0.2392 |
December 31, 2012 | -0.2399 |
September 30, 2012 | -0.3813 |
June 30, 2012 | -0.8969 |
March 31, 2012 | -0.8967 |
December 31, 2011 | -0.9061 |
September 30, 2011 | -0.8045 |
June 30, 2011 | -0.8014 |
March 31, 2011 | -0.7072 |
December 31, 2010 | -0.7118 |
September 30, 2010 | -0.7108 |
June 30, 2010 | -0.7288 |
March 31, 2010 | -0.7381 |
December 31, 2009 | -0.7473 |
September 30, 2009 | -0.7487 |
June 30, 2009 | -0.7801 |
March 31, 2009 | -0.8235 |
December 31, 2008 | -0.8361 |
September 30, 2008 | -0.8948 |
June 30, 2008 | -1.020 |
Date | Value |
---|---|
March 31, 2008 | -1.046 |
December 31, 2007 | -1.041 |
September 30, 2007 | -1.324 |
June 30, 2007 | -0.9961 |
March 31, 2007 | -0.9349 |
December 31, 2006 | -0.4827 |
September 30, 2006 | -0.8335 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
December 31, 2005 | 0.00 |
September 30, 2005 | 0.00 |
June 30, 2005 | 0.00 |
March 31, 2005 | 0.00 |
December 31, 2004 | 0.00 |
September 30, 2004 | 1.586 |
June 30, 2004 | 0.7661 |
March 31, 2004 | 0.4205 |
December 31, 2003 | 0.3146 |
September 30, 2003 | 0.5769 |
June 30, 2003 | 0.44 |
March 31, 2003 | 0.3358 |
December 31, 2002 | 1.371 |
September 30, 2002 | 0.00 |
June 30, 2002 | 0.00 |
March 31, 2002 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 0.279M |
Total Liabilities (Quarterly) | 11.66M |
Shareholders Equity (Quarterly) | -11.38M |